Patents by Inventor Angela M. Ginkel

Angela M. Ginkel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment for basal cell carcinoma
    Patent number: 8835394
    Abstract: The present invention provides a method of treating basal cell carcinoma in a subject. Generally, the method includes administering to the subject an amount of IRM compound effective for treating basal cell carcinoma in a treatment cycle that includes at least two consecutive days in which the IRM compound is administered and at least one day in which the IRM compound is not administered.
    Type: Grant
    Filed: October 18, 2011
    Date of Patent: September 16, 2014
    Assignee: Medicis Pharmaceutical Corporation
    Inventors: Mary L. Owens, Terrance L. Fox, Angela M. Ginkel
  • TREATMENT FOR BASAL CELL CARCINOMA
    Publication number: 20120035205
    Abstract: The present invention provides a method of treating basal cell carcinoma in a subject. Generally, the method includes administering to the subject an amount of IRM compound effective for treating basal cell carcinoma in a treatment cycle that includes at least two consecutive days in which the IRM compound is administered and at least one day in which the IRM compound is not administered.
    Type: Application
    Filed: October 18, 2011
    Publication date: February 9, 2012
    Applicant: Graceway Pharmaceuticals. LLC
    Inventors: Mary L. Owens, Terrance L. Fox, Angela M. Ginkel
  • Treatment for basal cell carcinoma
    Publication number: 20100197722
    Abstract: The present invention provides a method of treating basal cell carcinoma in a subject. Generally, the method includes administering to the subject an amount of IRM compound effective for treating basal cell carcinoma in a treatment cycle that includes at least two consecutive days in which the IRM compound is administered and at least one day in which the IRM compound is not administered.
    Type: Application
    Filed: April 2, 2010
    Publication date: August 5, 2010
    Applicant: Graceway Pharmaceuticals, LLC
    Inventors: Mary L. Owens, Terrance L. Fox, Angela M. Ginkel
  • Treatment for basal cell carcinoma
    Patent number: 7696159
    Abstract: The present invention provides a method of treating basal cell carcinoma in a subject. Generally, the method includes administering to the subject an amount of IRM compound effective for treating basal cell carcinoma in a treatment cycle that includes at least two consecutive days in which the IRM compound is administered and at least one day in which the IRM compound is not administered.
    Type: Grant
    Filed: January 15, 2008
    Date of Patent: April 13, 2010
    Assignee: Graceway Pharmaceuticals, LLC
    Inventors: Mary L. Owens, Terrance L. Fox, Angela M. Ginkel
  • Treatment for basal cell carcinoma
    Publication number: 20040192585
    Abstract: The present invention provides a method of treating basal cell carcinoma in a subject. Generally, the method includes administering to the subject an amount of IRM compound effective for treating basal cell carcinoma in a treatment cycle that includes at least two consecutive days in which the IRM compound is administered and at least one day in which the IRM compound is not administered.
    Type: Application
    Filed: March 24, 2004
    Publication date: September 30, 2004
    Applicant: 3M Innovative Properties Company
    Inventors: Mary L. Owens, Terrance L. Fox, Angela M. Ginkel